Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 482-484

  Bruining, Hilgo ^a   Bootsma, Atte H ^a   Koper, Jan W ^a   Bonjer, Jaap ^a   De Jong, Frank H ^b   Lamberts, Steven W J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE;

ADIPOSE TISSUE; ADRENAL SUPPRESSION; ADRENALECTOMY; ADULT; BODY COMPOSITION; BODY MASS; CASE REPORT; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; FERTILITY; HUMAN; LAPAROSCOPIC SURGERY; LIBIDO; LUTEAL PHASE; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STEROID 21 MONOOXYGENASE DEFICIENCY; WEIGHT REDUCTION;

EID: 0035092463     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.2.7208     Document Type: Conference Paper

References (30)

1. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
2. Molecular pathology of 21-hydroxylase deficiency
3. Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency
4. Adult height and fertility in men with congenital virilizing adrenal hyperplasia
5. Longer term outcome in females with congenital adrenal hyperplasia (CAH): The Cardiff experience
6. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
7. The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia
8. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency
9. Adrenals of patients with severe forms of CAH do more harm than good
10. Growth and sexual maturation in treated congenital adrenal hyperplasia
11. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency
12. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy
13. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency
14. Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First result of a cross-sectional quality of life evaluation
15. Gonadotropin output in congenital adrenal hyperplasia: Effects in congenital hyperplasia before and after adrenal suppression
16. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effect on height, sexual maturation and fertility
17. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
18. Treatment of congenital adrenal hyperplasia: The case for adrenalectomy
19. Adrenalektomie als therapie bei schwer einstellbarem adrenogenitalen syndrom
20. Ovarian steroidogenesis in an adrenolectomized girl with 21-hydroxylase deficiency
21. Prophylactic adrenalectomy of a three-year-old girl with congenital adrenal hyperplasia: Pre- and postoperative studies
22. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
23. Effectiveness and safety of laparoscopic adrenalectomy
24. Comparison of three techniques for adrenalectomy
25. Therapeutic controversy: The role of laparoscopic surgery in adrenal disease
26. Rapid DNA analysis by allele-specific PCR for detection of mutations in the steroid 21-hydroxylase gene
27. Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency
28. Naturally occurring adrenal steroids with sal: Losing properties: Relationship to congenital adrenal hyperplasia
29. Dehydroepiandrosterone replacement in women with adrenal insufficiency
30. Dehydroepiandrosterone for adrenal insufficiency